Le Fontanil, France

Madeleine Broll


Average Co-Inventor Count = 5.4

ph-index = 3

Forward Citations = 29(Granted Patents)


Location History:

  • Le Fontanil, FR (1977)
  • Grenoble, FR (1977)
  • St. Egreve, FR (1979)
  • Saint-Egreve, FR (1981)

Company Filing History:


Years Active: 1977-1981

Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Madeleine Broll

Introduction

Madeleine Broll is a prominent inventor based in Le Fontanil, France. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with therapeutic applications. With a total of 5 patents, her work has garnered attention for its potential impact on drug development.

Latest Patents

Among her latest patents, Broll has developed pharmaceutically active cyclohexyl compounds and their preparation. These chemical compounds are useful as active ingredients in drugs due to their anticonvulsant and/or antianoxic activity. The compounds have a general formula that includes various functional groups, making them versatile in medicinal applications. Another notable patent involves indole derivatives, which are designed to serve as antidepressant and/or antiaggressive agents. These derivatives also feature a complex structure that allows for a range of therapeutic uses.

Career Highlights

Broll is currently associated with Labaz, where she continues to innovate and contribute to the pharmaceutical industry. Her work is characterized by a commitment to advancing medical science through the development of new chemical compounds.

Collaborations

Throughout her career, Broll has collaborated with notable colleagues such as Pierre Luc Eymard and Charles Pigerol. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the quality of her inventions.

Conclusion

Madeleine Broll's contributions to the field of pharmaceuticals exemplify the importance of innovation in drug development. Her patents reflect a dedication to creating effective therapeutic agents that can improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…